Scientific articles 14 May 2026 In vitro profiling of Trypanosoma cruzi inhibitors identified from high throughput screening and application to parasite painting International Journal for Parasitology: Drugs and Drug Resistance
Statements 15 May 2026 DNDi statement on hantavirus outbreak: ‘Investment in pandemic preparedness efforts remains insufficient.’
Scientific articles 13 May 2026 Chemical genetics reveals Leishmania KKT2 and CRK9 kinase activity is required for cell cycle progression PLOS Pathogens
Press releases 12 May 2026 DNDi welcomes GHIT support for global evaluation and registration of fosravuconazole for eumycetoma, in collaboration with Eisai
In the media 29 Apr 2026 Thailand approves ravidasvir, a new drug for hepatitis C, increasing chances of complete cure Thai Rath
Scientific articles 14 May 2026 Mycetoma as a major cause of limb amputation in Northeastern Ethiopia: A facility-based retrospective study PLOS Neglected Tropical Diseases
Scientific articles 30 Apr 2026 Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination npj Antimicrobials and Resistance
In the media 29 Apr 2026 ไทยรับรอง “ราวิดาสเวียร์” ยาใหม่รักษาไวรัสตับอักเสบซี เพิ่มโอกาสรักษาหายขาด Thai Rath
Press releases 27 Apr 2026 Thailand registers ravidasvir, a simple-to-use and effective antiviral for hepatitis C, expanding treatment options for Thai patients
In the media 25 Apr 2026 ‘Estamos na fase de eliminação’: RD Congo avança no combate à doença que matou milhões na África Alma Preta
In the media 24 Apr 2026 Dengue treatments in 2-3 years, but cases set to rise with climate change Times of India
In the media 23 Apr 2026 India eyes dengue treatment rollout within five years as vaccine pipeline advances The New Indian Express
Statements 28 Feb 2023 DNDi’s submission to the Technical Assessment component of the first Global Stocktake
Statements 22 Feb 2023 DNDi comments on the zero draft of the WHO CA+ for consideration of the Intergovernmental Negotiating Body at INB4 & 5
Statements 2 Dec 2022 DNDi‘s comments on the conceptual zero draft for the consideration of the Intergovernmental Negotiating Body at INB3
Statements 29 Sep 2022 DNDi intervention at the Intergovernmental Negotiating Body second round of public hearings
Statements 18 Jul 2022 DNDi‘s comments on the working draft of the WHO CAll for the consideration of the INB at its second meeting
Statements 23 Jun 2022 DNDi Executive Director Dr Bernard Pécoul’s address to the Kigali Summit on Malaria and NTDs
Statements 15 Jun 2022 DNDi endorses consensus statement on gender-responsive international instrument for pandemic prevention, preparedness, and response
Statements 18 Apr 2022 DNDi‘s initial comments on the Intergovernmental Negotiating Body deliberations
Statements 12 Apr 2022 DNDi intervention at the Intergovernmental Negotiating Body first round of public hearings